COVID-19 in early childhood disrupts the gut microbiome - even without symptoms - and may dampen key immune pathways. A new study sheds light on this underappreciated risk. Let’s break it down🧵
Researchers studied children under 2 years old with mild COVID-19.
No GI symptoms!
Still, their gut microbiome looked very different from healthy peers.
Less diversity
Loss of protective bacteria
Rise in opportunistic bugs
Predicted suppression of immune-related pathways
Why does this matter?
Because early childhood is when the immune system learns - and the gut microbiome is the teacher.
Disrupt the microbial community, and you risk shaping immune responses in unhealthy ways.
In infected kids, researchers found:
Faecalibacterium, Clostridium, Ruminococcus (anti-inflammatory species)
Escherichia, Streptococcus, Enterococcus (opportunists)
That’s textbook dysbiosis - a disrupted, less balanced microbial ecosystem.
Functionally, their gut microbiota also showed reduced potential to support key immune functions:
IL-17 and Th17 signaling!
NOD- and Toll-like receptor pathways
Fc receptor-mediated phagocytosis
All critical for detecting and clearing viruses, especially at mucosal surfaces.
What’s striking:
These were mild cases, without GI symptoms.
But changes in the gut microbiome were measurable and meaningful.
And in this age group, the consequences could be long-term.
Other studies have found similar patterns:
Xu et al. 2021: early disruption of gut and airway microbiome in kids
Nashed et al. 2021: altered gut bacteria in asymptomatic infants
Romani et al. 2022: lower diversity, more pathogens in COVID+ children
Wang et al. 2023 (Omicron): increase in Escherichia, Prevotella, drop in Bifidobacterium, Blautia, etc.
So what are we looking at?
An infection that disrupts gut ecology during a critical window for immune imprinting
Loss of microbial training for immune regulation
Possible shift toward chronic inflammation or poor pathogen defense!
Maybe a setup for long COVID?
Bottom line:
Gut health matters - even if the child looks fine.
The immune system is being shaped in the background.
And that’s not all.
The gut and brain are tightly linked - via the gut–brain axis.
Microbiome changes in early life have been tied to-
altered brain development
behavioral outcomes
cognitive delays
COVID-19 may quietly disrupt this balance.
We urgently need:
longitudinal studies
neurodevelopmental follow-up
microbiome-supportive care
and better prevention of early-life infection.
One recent review Tzitiridou‑Chatzopoulou et al., 2024 highlights how early gut dysbiosis - especially in the first 3 years of life - can alter brain development and increase the risk of long-term health issues.
The microbiome isn’t just shaping immunity. It’s wiring the brain. mdpi.com/2227-9067/11/5…
Kim at al., Altered Gut Microbiota and Predicted Immune Dysregulation in Early Childhood SARS-CoV-2 Infection. Microorganisms (2025). mdpi.com/2076-2607/13/8…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
More than 2 years after infection, people with Long COVID still show signs of a leaky blood-brain barrier (BBB) - the brain’s protective filter.
A new MRI study links this persistent leakiness to motor dysfunction. Here’s what that means🧵
The BBB acts like a security checkpoint for the brain.
It keeps out toxins, viruses, immune cells - anything that could harm sensitive brain tissue.
When the barrier breaks down, the brain becomes exposed to inflammation, immune attacks, and possibly long-term damage.
This study used a noninvasive MRI technique - WEPCAST.
It tracks how easily water - a tiny molecule - crosses the BBB. That makes it more sensitive than standard MRI with contrast or spinal taps.
High precision.
Metformin cut the risk of long COVID.
A randomized, placebo-controlled trial tested a short course of metformin given during acute COVID.
While the primary endpoint didn’t reach the pre-specified threshold, some secondary outcomes were striking🧵
A big US study (HEROS, 1156 people, May 2020-Feb 2021) found something surprising.
If you had a rhinovirus (common cold) in the past month, your chance of catching COVID was 48% lower.
If you still got it, your viral load was almost 10× lower.🧵
Why?
Rhinovirus flips on a powerful interferon alarm in your airway cells.
Result - 24 antiviral genes (RIG-I, MDA5, IFIT1…) are primed and ready to slow down other viruses - including SARS-CoV-2.
The effect is instant:
These genes fire right in the airway epithelium, so the defense starts before immune cells even arrive.
Long COVID & viral persistence - new evidence
A new study detected a peptide fragment specific to SARS-CoV-2 nsp3 in blood extracellular vesicles (EVs) from Long COVID patients - months to years after infection.
Let’s unpack why this matters.🧵
EVs are tiny membrane packages released by cells, carrying proteins, RNA, and lipids.
They can travel in blood, cross biological barriers, and deliver their contents to other cells - bypassing normal immune surveillance!
The detected peptide - GSLPINVIVFDGK - is uniquely part of nsp3, a large viral enzyme encoded by ORF1ab.
Nsp3 is crucial for SARS-CoV-2 replication and immune evasion.
Importantly - the study found the peptide, not necessarily the entire intact protein.
Even without live virus, blood serum can carry signals powerful enough to change how healthy tissue works.
A new peer-reviewed study shows serum from ME/CFS and long COVID patients can directly impair muscle function in lab-grown human muscle.
5 years in, we still don’t know exactly which factors are responsible 🧵
The team built sophisticated 3D mini-muscles from human myoblasts. These bioengineered tissues contract when electrically stimulated, much like real muscles.
Then they bathed them in serum from ME/CFS or long COVID patients and watched what happened.
The results were striking.
After just 48 hours, previously healthy muscle tissue showed:
weaker contractions,
shorter endurance,
disrupted calcium (Ca2+) regulation,
clear signs of mitochondrial stress.
In short - muscles that were working perfectly started behaving like diseased ones.
Post-COVID pulmonary fibrosis (PC19-PF) = permanent scarring of lung tissue after SARS-CoV-2 infection.
Not just leftover inflammation - it’s a distinct biological state.
Some patients improve on their own. Others? The scarring progresses. Detecting it early is critical. Review🧵
How common? Depends who you look at
Hospitalized patients: 30-40% show PF signs at 6-12 months.
General population: lower, but true numbers are unknown.
Research bias alert: the sickest patients are followed most closely, so mild cases are often missed.
Key risk factors for PC19-PF
Severe COVID (especially ICU/ventilation)
Older age
Comorbidities (COPD, diabetes, cardiovascular disease)
Earlier variants (wild-type, Delta) posed a higher risk than Omicron.
Each factor adds biological weight toward fibrosis.